Autonomix Medical Inc (NASDAQ: AMIX)’s stock price has increased by 10.80 compared to its previous closing price of 1.25. However, the company has seen a 11.69% increase in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-27 that Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need indications
Is It Worth Investing in Autonomix Medical Inc (NASDAQ: AMIX) Right Now?
Additionally, the 36-month beta value for AMIX is -3.39. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for AMIX is 2.19M and currently, short sellers hold a 8.29% ratio of that float. The average trading volume of AMIX on June 27, 2025 was 211.34K shares.
AMIX’s Market Performance
AMIX stock saw a decrease of 11.69% in the past week, with a monthly decline of -18.53% and a quarterly a decrease of -27.49%. The volatility ratio for the week is 7.11%, and the volatility levels for the last 30 days are 7.63% for Autonomix Medical Inc (AMIX). The simple moving average for the last 20 days is -0.70% for AMIX stock, with a simple moving average of -72.57% for the last 200 days.
AMIX Trading at -18.78% from the 50-Day Moving Average
After a stumble in the market that brought AMIX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.73% of loss for the given period.
Stock Fundamentals for AMIX
The total capital return value is set at -1.11. Equity return is now at value -145.09, with -118.76 for asset returns.
Based on Autonomix Medical Inc (AMIX), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -7.1. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -61.44.
Currently, EBITDA for the company is -11.59 million with net debt to EBITDA at 0.81. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.63.
Conclusion
In conclusion, Autonomix Medical Inc (AMIX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
